• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

理解特发性颅内高压(IIH)的病理生理学:近期进展综述。

Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments.

机构信息

Department of Neuroscience, Monash University Faculty of Medicine Nursing and Health Sciences, Clayton, Victoria, Australia

Department of Neurology, Alfred Hospital, Melbourne, Victoria, Australia.

出版信息

J Neurol Neurosurg Psychiatry. 2024 Mar 13;95(4):375-383. doi: 10.1136/jnnp-2023-332222.

DOI:10.1136/jnnp-2023-332222
PMID:37798095
Abstract

Idiopathic intracranial hypertension (IIH) is a condition of significant morbidity and rising prevalence. It typically affects young people living with obesity, mostly women of reproductive age, and can present with headaches, visual abnormalities, tinnitus and cognitive dysfunction. Raised intracranial pressure without a secondary identified cause remains a key diagnostic feature of this condition, however, the underlying pathophysiological mechanisms that drive this increase are poorly understood. Previous theories have focused on cerebrospinal fluid (CSF) hypersecretion or impaired reabsorption, however, the recent characterisation of the glymphatic system in many other neurological conditions necessitates a re-evaluation of these hypotheses. Further, the impact of metabolic dysfunction and hormonal dysregulation in this population group must also be considered. Given the emerging evidence, it is likely that IIH is triggered by the interaction of multiple aetiological factors that ultimately results in the disruption of CSF dynamics. This review aims to provide a comprehensive update on the current theories regarding the pathogenesis of IIH.

摘要

特发性颅内高压(IIH)是一种发病率高且呈上升趋势的疾病。它通常影响肥胖的年轻人,主要是育龄妇女,其症状包括头痛、视力异常、耳鸣和认知功能障碍。颅内压升高而无明确的继发原因仍然是这种疾病的一个关键诊断特征,然而,导致这种升高的潜在病理生理机制仍知之甚少。以前的理论集中在脑脊液(CSF)分泌过多或吸收受损上,然而,最近在许多其他神经疾病中对糖质系统的描述需要重新评估这些假设。此外,还必须考虑代谢功能障碍和激素失调对这一人群的影响。鉴于新出现的证据,IIH 很可能是由多种病因因素相互作用引发的,这些因素最终导致 CSF 动力学的破坏。这篇综述旨在提供关于 IIH 发病机制的现有理论的全面更新。

相似文献

1
Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments.理解特发性颅内高压(IIH)的病理生理学:近期进展综述。
J Neurol Neurosurg Psychiatry. 2024 Mar 13;95(4):375-383. doi: 10.1136/jnnp-2023-332222.
2
Role of the glymphatic system in idiopathic intracranial hypertension.糖胺聚糖系统在特发性颅内高压中的作用。
Clin Neurol Neurosurg. 2022 Nov;222:107446. doi: 10.1016/j.clineuro.2022.107446. Epub 2022 Sep 17.
3
The Role of Arachnoid Granulations and the Glymphatic System in the Pathophysiology of Idiopathic Intracranial Hypertension.蛛网膜颗粒和脑淋巴系统在特发性颅内高压病理生理学中的作用。
Curr Neurol Neurosci Rep. 2020 May 22;20(7):20. doi: 10.1007/s11910-020-01044-4.
4
Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management.成人特发性颅内高压的最新证据:病理生理学与管理
J Neurol Neurosurg Psychiatry. 2016 Sep;87(9):982-92. doi: 10.1136/jnnp-2015-311302. Epub 2016 Feb 17.
5
Modelling idiopathic intracranial hypertension in rats: contributions of high fat diet and testosterone to intracranial pressure and cerebrospinal fluid production.在大鼠中模拟特发性颅内高压:高脂肪饮食和睾酮对颅内压和脑脊液生成的影响。
Fluids Barriers CNS. 2023 Jun 16;20(1):44. doi: 10.1186/s12987-023-00436-1.
6
Idiopathic Intracranial Hypertension: Implications for the Otolaryngologist.特发性颅内高压:对耳鼻喉科医生的启示
Otolaryngol Clin North Am. 2022 Jun;55(3):579-594. doi: 10.1016/j.otc.2022.02.005. Epub 2022 Apr 27.
7
Idiopathic Intracranial Hypertension - Challenges and Pearls.特发性颅内高压 - 挑战与亮点。
Neurol India. 2021 Nov-Dec;69(Supplement):S434-S442. doi: 10.4103/0028-3886.332276.
8
Advances in the understanding of headache in idiopathic intracranial hypertension.特发性颅内高压性头痛的研究进展。
Curr Opin Neurol. 2019 Feb;32(1):92-98. doi: 10.1097/WCO.0000000000000651.
9
Emerging themes in idiopathic intracranial hypertension.特发性颅内高压的新兴主题。
J Neurol. 2020 Dec;267(12):3776-3784. doi: 10.1007/s00415-020-10090-4. Epub 2020 Jul 22.
10
An update on the pathophysiology of idiopathic intracranial hypertension alias pseudotumor cerebri.特发性颅内高压(又称假性脑瘤)病理生理学的最新进展。
Agri. 2015;27(2):63-72. doi: 10.5505/agri.2015.22599.

引用本文的文献

1
Idiopathic Intracranial Hypertension in Neonates, Infants, and Toddlers.新生儿、婴儿和幼儿特发性颅内高压
J Clin Med. 2025 Jul 17;14(14):5084. doi: 10.3390/jcm14145084.
2
Epidemiological Patterns, Treatment Response, and Metabolic Correlations of Idiopathic Intracranial Hypertension: A United States-Based Study From 1990 to 2024.特发性颅内高压的流行病学模式、治疗反应及代谢相关性:一项基于美国的1990年至2024年的研究
ASIDE Intern Med. 2025 Jan;1(1):31-39. doi: 10.71079/aside.im.0000012282413. Epub 2024 Dec 28.
3
Efficacy and Safety of Optic Nerve Sheath Fenestration for Idiopathic Intracranial Hypertension. A Subgroup-Focused Systematic Review and Meta-Analysis.
视神经鞘开窗术治疗特发性颅内高压的疗效与安全性。一项聚焦亚组的系统评价和Meta分析。
ASIDE Intern Med. 2025 Jan;1(3):7-14. doi: 10.71079/aside.im.1542545. Epub 2025 Apr 15.
4
The Glymphatic System and Its Role in Neurovascular Diseases.类淋巴系统及其在神经血管疾病中的作用。
J Neuroendovasc Ther. 2025;19(1). doi: 10.5797/jnet.ra.2025-0020. Epub 2025 Jun 21.
5
Effectiveness of Topiramate Versus Acetazolamide in the Management of Idiopathic Intracranial Hypertension: ASystematic Review and Meta-Analysis.托吡酯与乙酰唑胺治疗特发性颅内高压的疗效:一项系统评价和荟萃分析
Medicina (Kaunas). 2025 Mar 4;61(3):450. doi: 10.3390/medicina61030450.
6
Outcomes of Stenting in Atypical Idiopathic Intracranial Hypertension Patients With Transverse Sinus Stenosis.横窦狭窄的非典型特发性颅内高压患者支架置入的结局
Brain Behav. 2025 Feb;15(2):e70351. doi: 10.1002/brb3.70351.
7
Efficacy of Tirzepatide Dual GIP/GLP-1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real-World Propensity Score-Matched Study.替尔泊肽双重GIP/GLP-1受体激动剂治疗特发性颅内高压患者的疗效。一项真实世界倾向评分匹配研究。
Endocrinol Diabetes Metab. 2025 Mar;8(2):e70019. doi: 10.1002/edm2.70019.
8
Liraglutide for idiopathic intracranial hypertension: a real-world propensity score-matched study.利拉鲁肽治疗特发性颅内高压:一项真实世界倾向评分匹配研究。
Ann Clin Transl Neurol. 2025 Apr;12(4):746-755. doi: 10.1002/acn3.52300. Epub 2025 Feb 13.
9
Stenting versus medical treatment for idiopathic intracranial hypertension based on a propensity score matching method.基于倾向评分匹配法的特发性颅内高压的支架置入术与药物治疗对比研究
Quant Imaging Med Surg. 2025 Jan 2;15(1):524-536. doi: 10.21037/qims-24-1417. Epub 2024 Dec 19.
10
The Impact of Idiopathic Intracranial Hypertension on Cardiovascular Disease Risk Among UK Women: An Obesity-Adjusted Analysis.特发性颅内高压对英国女性心血管疾病风险的影响:一项肥胖校正分析。
ASIDE Intern Med. 2025 Jan;1(1):1-11. doi: 10.71079/h1fr8h68. Epub 2024 Nov 17.